189 related articles for article (PubMed ID: 31870123)
1. Exosomes as a Surrogate Marker for Autophagy in Peripheral Blood, Correlative Data from Phase I Study of Chloroquine in Combination with Carboplatin/Gemcitabine in Advanced Solid Tumors.
Abdel Karim N; Gaber O; Aljohani HM; Eldessouki I; Bahassi EM; Morris J
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3789-3796. PubMed ID: 31870123
[TBL] [Abstract][Full Text] [Related]
2. A Phase I Trial to Determine the Safety and Tolerability of Autophagy Inhibition Using Chloroquine or Hydroxychloroquine in Combination With Carboplatin and Gemcitabine in Patients With Advanced Solid Tumors.
Karim NA; Ullah A; Ahmad I; Bahassi E; Olowokure O; Khaled A; Davis H; Morris JC
Front Oncol; 2022; 12():811411. PubMed ID: 35574311
[TBL] [Abstract][Full Text] [Related]
3. Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma.
Boone BA; Bahary N; Zureikat AH; Moser AJ; Normolle DP; Wu WC; Singhi AD; Bao P; Bartlett DL; Liotta LA; Espina V; Loughran P; Lotze MT; Zeh HJ
Ann Surg Oncol; 2015 Dec; 22(13):4402-10. PubMed ID: 25905586
[TBL] [Abstract][Full Text] [Related]
4. Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis.
Lin YC; Lin JF; Wen SI; Yang SC; Tsai TF; Chen HE; Chou KY; Hwang TI
Kaohsiung J Med Sci; 2017 May; 33(5):215-223. PubMed ID: 28433067
[TBL] [Abstract][Full Text] [Related]
5. Novel Roles of Chloroquine and Hydroxychloroquine in Graves' Orbitopathy Therapy by Targeting Orbital Fibroblasts.
Guo Y; Li H; Chen X; Yang H; Guan H; He X; Chen Y; Pokharel S; Xiao H; Li Y
J Clin Endocrinol Metab; 2020 Jun; 105(6):1906-17. PubMed ID: 32249902
[TBL] [Abstract][Full Text] [Related]
6. The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition.
Fukuda T; Oda K; Wada-Hiraike O; Sone K; Inaba K; Ikeda Y; Miyasaka A; Kashiyama T; Tanikawa M; Arimoto T; Kuramoto H; Yano T; Kawana K; Osuga Y; Fujii T
Gynecol Oncol; 2015 Jun; 137(3):538-45. PubMed ID: 25842161
[TBL] [Abstract][Full Text] [Related]
7. Abrogation of Autophagy by Chloroquine Alone or in Combination with mTOR Inhibitors Induces Apoptosis in Neuroendocrine Tumor Cells.
Avniel-Polak S; Leibowitz G; Riahi Y; Glaser B; Gross DJ; Grozinsky-Glasberg S
Neuroendocrinology; 2016; 103(6):724-37. PubMed ID: 26619207
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of autophagy by chloroquine enhances the antitumor activity of gemcitabine for gallbladder cancer.
Wang FT; Wang H; Wang QW; Pan MS; Li XP; Sun W; Fan YZ
Cancer Chemother Pharmacol; 2020 Aug; 86(2):221-232. PubMed ID: 32654071
[TBL] [Abstract][Full Text] [Related]
9. Dose escalating study of biweekly gemcitabine and carboplatin in patients with advanced cancer.
Dudek AZ; Larson T; Keshtgarpour M; Kumar P
Am J Clin Oncol; 2007 Oct; 30(5):481-6. PubMed ID: 17921707
[TBL] [Abstract][Full Text] [Related]
10. Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer: A Phase 2 Randomized Clinical Trial.
Karasic TB; O'Hara MH; Loaiza-Bonilla A; Reiss KA; Teitelbaum UR; Borazanci E; De Jesus-Acosta A; Redlinger C; Burrell JA; Laheru DA; Von Hoff DD; Amaravadi RK; Drebin JA; O'Dwyer PJ
JAMA Oncol; 2019 Jul; 5(7):993-998. PubMed ID: 31120501
[TBL] [Abstract][Full Text] [Related]
11. Encouraging long-term survival following autophagy inhibition using neoadjuvant hydroxychloroquine and gemcitabine for high-risk patients with resectable pancreatic carcinoma.
AlMasri SS; Zenati MS; Desilva A; Nassour I; Boone BA; Singhi AD; Bartlett DL; Liotta LA; Espina V; Loughran P; Lotze MT; Paniccia A; Zeh HJ; Zureikat AH; Bahary N
Cancer Med; 2021 Oct; 10(20):7233-7241. PubMed ID: 34559451
[TBL] [Abstract][Full Text] [Related]
12. Autophagy is needed for the growth of pancreatic adenocarcinoma and has a cytoprotective effect against anticancer drugs.
Hashimoto D; Bläuer M; Hirota M; Ikonen NH; Sand J; Laukkarinen J
Eur J Cancer; 2014 May; 50(7):1382-90. PubMed ID: 24503026
[TBL] [Abstract][Full Text] [Related]
13. Chloroquine and Chemotherapeutic Compounds in Experimental Cancer Treatment.
Agalakova NI
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256019
[TBL] [Abstract][Full Text] [Related]
14. Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells.
Sasaki K; Tsuno NH; Sunami E; Tsurita G; Kawai K; Okaji Y; Nishikawa T; Shuno Y; Hongo K; Hiyoshi M; Kaneko M; Kitayama J; Takahashi K; Nagawa H
BMC Cancer; 2010 Jul; 10():370. PubMed ID: 20630104
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer.
Chiappori A; Simon G; Williams C; Haura E; Rocha-Lima C; Wagner H; Bepler G; Antonia S
Oncology; 2005; 68(4-6):382-90. PubMed ID: 16020967
[TBL] [Abstract][Full Text] [Related]
16. Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors.
Lockhart AC; Bauer TM; Aggarwal C; Lee CB; Harvey RD; Cohen RB; Sedarati F; Nip TK; Faessel H; Dash AB; Dezube BJ; Faller DV; Dowlati A
Invest New Drugs; 2019 Feb; 37(1):87-97. PubMed ID: 29781056
[TBL] [Abstract][Full Text] [Related]
17. Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial.
Tan AR; Wright GS; Thummala AR; Danso MA; Popovic L; Pluard TJ; Han HS; Vojnović Ž; Vasev N; Ma L; Richards DA; Wilks ST; Milenković D; Yang Z; Antal JM; Morris SR; O'Shaughnessy J
Lancet Oncol; 2019 Nov; 20(11):1587-1601. PubMed ID: 31575503
[TBL] [Abstract][Full Text] [Related]
18. A correlative biomarker analysis of the combination of bevacizumab and carboplatin-based chemotherapy for advanced nonsquamous non-small-cell lung cancer: results of the phase II randomized ABIGAIL study (BO21015).
Mok T; Gorbunova V; Juhasz E; Szima B; Burdaeva O; Orlov S; Yu CJ; Archer V; Hilton M; Delmar P; Pallaud C; Reck M
J Thorac Oncol; 2014 Jun; 9(6):848-55. PubMed ID: 24807156
[TBL] [Abstract][Full Text] [Related]
19. Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors.
Galsky MD; Posner M; Holcombe RF; Lee KM; Misiukiewicz K; Tsao CK; Godbold J; Soto R; Gimpel-Tetra K; Lowe N; Oh WK
Cancer Chemother Pharmacol; 2014 Sep; 74(3):465-71. PubMed ID: 25023489
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy of carboplatin and gemcitabine against solid tumors: a phase I trial.
Tassinari D; Drudi G; Panzini I; Pasini G; Arcangeli V; Fochessati F; Gianni L; Mianulli AM; Oliverio G; Pasquini E; Sartori S; Ravaioli A
Int J Clin Oncol; 2001 Dec; 6(6):279-83. PubMed ID: 11828946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
